Purine and Indole Derivatives Show Virus-Suppressing Effects in Infected Mammalian Cells

Researchers in Bulgaria have reported the results of a pilot in vitro study examining whether two chemically distinct small molecules, the purine derivative aminophylline and the indole derivative 61-tartrat, can suppress viral replication in mammalian cell cultures at concentrations that remain non-cytotoxic to the host cells. The work, published in BMC Pharmacology and Toxicology, addresses a central challenge in antiviral drug development: identifying a therapeutic window in which a compound exerts a meaningful antiviral effect without damaging the very cells it is meant to protect. The study was carried out by Iskra Sainova and Vera Kolyovska of the Institute of Experimental Morphology, Pathology and Anthropology with Museum at the Bulgarian Academy of Sciences, together with colleagues from the University Hospital for Neurology and Psychiatry St. Naum and the Medical University of Sofia, and was supported by a grant from the Bulgarian Ministry of Education and Science.

The experimental design rested on two embryonic mammalian cell lines of different origin: EBTr cells, derived from embryonic bovine trachea, and 3T3 cells, a mouse embryonic fibroblast line. These lines are standard tools in virology and toxicology laboratories, valued for their robust growth in culture and their well-characterized responses to viral infection and chemical stress. Using two cell lines from different species allowed the investigators to ask whether any observed effects were consistent across mammalian backgrounds or were instead specific to one cellular context. This cross-species comparison is particularly important in pilot studies, where the goal is to establish whether a phenomenon is general enough to justify further, more resource-intensive investigation.

To create the infections, the researchers inoculated cultures of both cell lines with a mixture of two vaccine strains of avipoxvirus, designated FK from fowl and Dessau from pigeon. Avipoxviruses are poxviruses that infect birds, and vaccine strains of these viruses are widely used in research because they can enter and express their genes in mammalian cells while producing a controlled, measurable cytopathogenic effect. By inoculating the cultures and then treating sub-populations of the infected cells with each of the two derivatives twenty-four hours after viral inoculation, the team could separate the effects of the compounds on established infection from their effects on uninfected cells. This timing is technically significant: a compound added after infection is tested for its ability to interfere with viral processes already underway inside the host cell, rather than merely blocking initial attachment or entry.

The readouts of the study were deliberately simple and complementary. The investigators determined the viral cytopathogenic effect, the visible damage that virus-infected cells sustain as replication proceeds, alongside the cytotoxic and antiviral influences of a range of concentrations of each substance. All values were assessed against control cultures of each cell line that had been neither inoculated with virus nor treated with the compounds. This dual control structure is what allows the separation of two phenomena that are otherwise easily conflated: a loss of cell viability in a treated, infected culture could reflect direct chemical toxicity, viral damage, or a combination of both. By comparing infected treated cultures against uninfected untreated controls, and by tracking viability at multiple time points after treatment, the researchers could begin to attribute observed changes to their most likely causes.

The headline finding of the study concerns the relative performance of the two derivatives. As a whole, the purine derivative aminophylline showed lower cytotoxicity but a stronger antiviral effect on virus-inoculated cells from both embryonic mammalian lines compared with the indole derivative 61-tartrat. In other words, across both the bovine EBTr and the mouse 3T3 backgrounds, aminophylline appeared to suppress the viral infection more effectively while harming the host cells less. This combination of properties is exactly what antiviral screening seeks: a compound that widens rather than narrows the gap between the concentration that inhibits the virus and the concentration that damages the cell.

A particularly informative technical observation came from comparing cell viability at the twenty-fourth and forty-eighth hours after treatment. The researchers determined a decrease in the viability of the inoculated cells from both cell types at the forty-eighth hour after treatment compared with the twenty-fourth hour. Crucially, they interpreted this result differently depending on the concentration of the derivatives. At low concentrations of the two compounds, the decline in viability was taken as evidence relevant to the antiviral comparison between them. At higher concentrations, however, the decreased viability of cells from both types was probably mainly attributable to the viral cytopathogenic effect itself rather than to the compounds. This kind of time- and concentration-dependent interpretation reflects a mature approach to cytotoxicity data, in which the same numerical change can carry different biological meanings in different experimental contexts.

From these data, the team was able to determine non-cytotoxic antiviral concentrations of each of the two derivatives that were nonetheless high enough to influence the cells of both types. Establishing such concentrations is the practical deliverable of a pilot study of this kind. It converts a qualitative observation, that a compound seems to help infected cells, into a quantitative starting point for future experiments: specific concentration ranges at which the compound can be applied without confounding the results by killing or stressing the host cells. The authors note that in this regard a strong analogy was assessed between the embryonic mammalian cells of bovine and mouse origin, meaning that the two lines behaved similarly enough that findings in one appear transferable to the other.

This cross-species consistency carries a broader implication that the authors highlight in their conclusions. The data, they write, suggest a possibility for future studies using mouse embryonic cells as a proven appropriate experimental in vitro model analogue to the respective human systems. The 3T3 mouse embryonic line is one of the most extensively characterized cell lines in biomedical research, and if antiviral and cytotoxic responses observed in EBTr cells are mirrored in 3T3 cells, researchers can design follow-up experiments on a well-standardized platform. The authors also situate their work within a wider literature on purine and indole chemistry in antiviral research, referencing work on Epstein-Barr virus, HIV, N6-methyladenosine modification of viral and cellular RNA, and epigenetic targets such as the histone methyltransferase DOT1L, whose inhibition by the compound EPZ004777 alters methylation at lysine 79 of histone H3. These references sketch the mechanistic landscape in which purine- and indole-based molecules are increasingly studied as modulators of viral and epigenetic processes.

It is worth being clear about the scope of what this pilot study does and does not establish. The experiments were performed in vitro, on vaccine strains of an avian poxvirus in rodent and bovine embryonic cells, and the compounds were tested at defined concentrations under controlled laboratory conditions. The results do not demonstrate efficacy against any human virus, nor do they establish clinical safety or dosing for either compound. Aminophylline itself is a familiar drug, long used in respiratory medicine as a bronchodilator, which gives it an established pharmacological profile in humans; however, the concentrations and mechanisms relevant to its observed antiviral activity in this cell culture system are a separate question from its classical clinical use. The value of the present work lies in defining the experimental conditions under which antiviral effects can be studied without cytotoxic confounding, and in validating a model system for that purpose.

Nevertheless, the study offers a useful methodological template for early-stage antiviral screening. By pairing two embryonic cell lines from different species, applying compounds after infection rather than before, measuring both cytopathogenic effect and cell viability over time, and interpreting viability losses in a concentration-dependent manner, the researchers assembled a picture in which aminophylline emerges as the more promising of the two derivatives for further antiviral investigation. The determination of non-cytotoxic, virus-suppressing concentrations for both aminophylline and 61-tartrat provides a concrete foundation on which subsequent studies, whether extending to additional viruses, to human cell systems, or to mechanistic dissection of how these purine and indole scaffolds interfere with viral replication, can now be built. As with all pilot studies, the findings are preliminary, but they are a documented, quantified first step rather than a speculative one.

Subject of Research: Non-cytotoxic, virus-suppressing concentrations of purine and indole derivatives in infected mammalian cell cultures

Article Title: A pilot study of non-cytotoxic, virus-suppressing concentrations of purine and indole derivatives on infected mammalian cells

Article References: Sainova, I., Kolyovska, V., Mihaylova, E., Dimitrova-Dikanarova, D., Hadjiolova, R., & Markova, T. (2026). A pilot study of non-cytotoxic, virus-suppressing concentrations of purine and indole derivatives on infected mammalian cells. BMC Pharmacology and Toxicology. https://doi.org/10.1186/s40360-026-01228-7

Image Credits: AI Generated

DOI: 10.1186/s40360-026-01228-7

Keywords: aminophylline, indole derivatives, purine derivatives, antiviral activity, cytotoxicity, avipoxvirus, embryonic mammalian cells, EBTr cells, 3T3 cells, viral cytopathogenic effect, in vitro model, pharmacology